Asma Mousavi

547 total citations · 1 hit paper
26 papers, 91 citations indexed

About

Asma Mousavi is a scholar working on Cardiology and Cardiovascular Medicine, Surgery and Epidemiology. According to data from OpenAlex, Asma Mousavi has authored 26 papers receiving a total of 91 indexed citations (citations by other indexed papers that have themselves been cited), including 14 papers in Cardiology and Cardiovascular Medicine, 10 papers in Surgery and 7 papers in Epidemiology. Recurrent topics in Asma Mousavi's work include Atrial Fibrillation Management and Outcomes (4 papers), Cardiac Imaging and Diagnostics (4 papers) and Diabetes, Cardiovascular Risks, and Lipoproteins (3 papers). Asma Mousavi is often cited by papers focused on Atrial Fibrillation Management and Outcomes (4 papers), Cardiac Imaging and Diagnostics (4 papers) and Diabetes, Cardiovascular Risks, and Lipoproteins (3 papers). Asma Mousavi collaborates with scholars based in Iran, United States and Canada. Asma Mousavi's co-authors include Amirmohammad Khalaji, Amir Hossein Behnoush, Alessandro Cannavò, Ahmad Riasi, Amir Hossein Mahdavi, Kamran Mansouri, Shayan Shojaei, Hamidreza Soleimani, John Nelson and Kaveh Hosseini and has published in prestigious journals such as SHILAP Revista de lepidopterología, Neuroscience & Biobehavioral Reviews and The American Journal of Cardiology.

In The Last Decade

Asma Mousavi

14 papers receiving 91 citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

The importance of assessing the triglyceride-glucose index (TyG) in patients with depression: A systematic review

2024 47 citations Amir Hossein Behnoush, Asma Mousavi et al. Neuroscience & Biobehavioral Reviews profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Asma Mousavi Iran	6	28	24	23	11	10	26	91
Agostino Rizzotto Italy	4	14 0.5×	20 0.8×	37 1.6×	6 0.5×		6	115
Alice Ferrero Italy	6	12 0.4×	66 2.8×	9 0.4×	37 3.4×	4 0.4×	13	186
Olga Lunegova Kyrgyzstan	4	22 0.8×	29 1.2×	23 1.0×	9 0.8×	5 0.5×	23	93
Alina Kerimkulova Kyrgyzstan	5	17 0.6×	28 1.2×	24 1.0×	10 0.9×	5 0.5×	17	90
Ignacio Manuel Gimenez-Alba Spain	3	5 0.2×	18 0.8×	12 0.5×	11 1.0×	2 0.2×	7	106
Dino Pedrotti Italy	6	9 0.3×	15 0.6×	15 0.7×	28 2.5×	3 0.3×	10	211
Xinhua Xiao China	8	15 0.5×	91 3.8×	9 0.4×	34 3.1×	2 0.2×	12	191
Javier Farias Argentina	5	13 0.5×	81 3.4×	24 1.0×	6 0.5×	8 0.8×	6	104
Alireza Ani Iran	8	15 0.5×	5 0.2×	12 0.5×	15 1.4×	2 0.2×	21	150
Rania Bounab France	4	15 0.5×	33 1.4×	46 2.0×	5 0.5×		4	137

Countries citing papers authored by Asma Mousavi

Since Specialization

Citations

This map shows the geographic impact of Asma Mousavi's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Asma Mousavi with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Asma Mousavi more than expected).

Fields of papers citing papers by Asma Mousavi

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Asma Mousavi. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Asma Mousavi. The network helps show where Asma Mousavi may publish in the future.

Co-authorship network of co-authors of Asma Mousavi

This figure shows the co-authorship network connecting the top 25 collaborators of Asma Mousavi. A scholar is included among the top collaborators of Asma Mousavi based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Asma Mousavi. Asma Mousavi is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Zamirian, Mahmood, et al.. (2025). Constrictive Pericarditis as a Rare Manifestation of Graft‐Versus‐Host Disease: A Case Report. Clinical Case Reports. 13(5). e70479–e70479.

Mousavi, Asma, Hamidreza Soleimani, Peyvand Parhizkar Roudsari, et al.. (2025). Time Trends in Major Adverse Cardiovascular Events After Percutaneous Coronary Intervention. JACC Advances. 4(2). 101526–101526.

Mousavi, Asma, Shayan Shojaei, کیوان صالحی, et al.. (2025). Direct oral anticoagulants versus low-molecular-weight heparin for thromboprophylaxis in cancer-related surgeries: A meta-analysis of efficacy and safety outcomes. American Heart Journal Plus Cardiology Research and Practice. 59. 100607–100607.

Shojaei, Shayan, et al.. (2025). Novel Lipid Biomarkers and Microvascular Complications in Patients with Diabetes Mellitus: A Systematic Review and Meta-analysis. Clinical Medicine Insights Endocrinology and Diabetes. 18. 753224629–753224629. 1 indexed citations

Shojaei, Shayan, Asma Mousavi, Mohammadreza Naderian, et al.. (2025). Artificial Intelligence in Risk Stratification and Outcome Prediction for Transcatheter Aortic Valve Replacement: A Systematic Review and Meta-Analysis. Journal of Personalized Medicine. 15(7). 302–302. 2 indexed citations

Azarboo, Alireza, et al.. (2025). Waist circumference and body surface area and the risk of developing new-onset atrial fibrillation: A systematic review and meta-analysis of observational studies. Heart & Lung. 72. 1–12. 1 indexed citations

Shojaei, Shayan, Asma Mousavi, Hamidreza Soleimani, et al.. (2025). Estimated glucose disposal rate and the risk of major adverse cardio-cerebrovascular outcomes and mortality in patients undergoing percutaneous coronary intervention: a retrospective cohort study. European journal of medical research. 30(1). 442–442.

Shojaei, Shayan, et al.. (2025). Linking Estimated Glucose Disposal Rate to Major Adverse Cardio-Cerebrovascular Events in Populations With and Without Diabetes: A Systematic Review and Meta-Analysis. Clinical Medicine Insights Endocrinology and Diabetes. 18. 753232030–753232030.

Mousavi, Asma, Amir Parsa Abhari, Erta Rajabi, et al.. (2025). Intensive Blood Pressure Control in Type 2 Diabetes: A Systematic Review and Meta-Analysis of Cardiovascular and Microvascular Outcomes. American Journal of Hypertension. 39(1). 48–62.

10.

Mousavi, Asma, Hamidreza Soleimani, Andrew M. Harrison, et al.. (2025). Safety, efficacy, and cardiovascular benefits of combination therapy with SGLT-2 inhibitors and GLP-1 receptor agonists in patients with diabetes mellitus: a systematic review and meta-analysis of randomized controlled trials. Diabetology & Metabolic Syndrome. 17(1). 68–68. 5 indexed citations

11.

Shojaei, Shayan, et al.. (2025). The role of cardiac positron emission tomography in prediction of atrial fibrillation rhythm: A systematic review and meta-analysis. Heart & Lung. 75. 125–135.

12.

Roudsari, Peyvand Parhizkar, et al.. (2025). Prognostic value of inflammatory markers including neutrophil to lymphocyte ratio, platelet to lymphocyte ratio, mean platelet volume, platelet distribution width, and red blood cell distribution width in viral hepatitis: A systematic review and meta-analysis. SHILAP Revista de lepidopterología. 5(4). 100229–100229.

13.

Mousavi, Asma, Shayan Shojaei, کیوان صالحی, et al.. (2025). Direct Oral Anticoagulants Versus Low-Molecular-Weight Heparin in Patients With Cancer-Associated Thrombosis: A Meta-Analysis of Randomized Controlled Trials. The American Journal of Cardiology. 254. 32–41. 2 indexed citations

14.

Mousavi, Asma, et al.. (2025). Optical Coherence Tomography Measurements Alteration in Patients with End-Stage Renal Disease after Hemodialysis. Ophthalmic Research. 68(1). 503–520.

15.

Mousavi, Asma, et al.. (2025). Ischemic modified albumin and thiol levels in Coronavirus disease 19: a systematic review and meta-analysis. PubMed. 9(1). 13–13. 1 indexed citations

16.

Soleimani, Hamidreza, Asma Mousavi, Shayan Shojaei, et al.. (2024). Safety and Effectiveness of High‐Intensity Statins Versus Low/Moderate‐Intensity Statins Plus Ezetimibe in Patients With Atherosclerotic Cardiovascular Disease for Reaching LDL‐C Goals: A Systematic Review and Meta‐Analysis. Clinical Cardiology. 47(8). e24334–e24334. 5 indexed citations

17.

Mousavi, Asma, et al.. (2024). Predictive potential of pre-procedural cardiac and inflammatory biomarkers regarding mortality following transcatheter aortic valve implantation: A systematic review and meta-analysis. Heart & Lung. 69. 229–240. 1 indexed citations

18.

Shojaei, Shayan, et al.. (2024). Periprocedural Changes of Serum Biomarkers in Predicting Complications Following Bariatric Surgery for Obesity: Systematic Review and Meta-analysis. Obesity Surgery. 34(6). 2198–2215. 5 indexed citations

19.

Mousavi, Asma, et al.. (2024). Efficacy and Safety of Sotatercept in Pulmonary Arterial Hypertension: A Systematic Review. 18(1).

20.

Behnoush, Amir Hossein, et al.. (2024). The importance of assessing the triglyceride-glucose index (TyG) in patients with depression: A systematic review. Neuroscience & Biobehavioral Reviews. 159. 105582–105582. 47 indexed citations breakdown →

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact